开放与腔内腹主动脉瘤修复术后再手术率比较
基于美国退伍军人事务部外科质量改进项目2007年10月至2013年10月数据,回顾性分析6677例腹主动脉瘤修复患者,476例(7.1%)需再手术。开放修复再手术率高于腔内修复(10.0% vs 6.3%,P < .01),且肠缺血和下肢缺血再手术率更高;腔内修复中支架置入率更高(2.8% vs 0.5%,P < .01)。控制合并症后,腔内修复是再手术的负性预测因素(P < .001)。
要点
- 开放修复再手术率10.0%,高于腔内修复的6.3%(P < .01)。
- 开放修复肠缺血再手术率0.7% vs 腔内0.3%(P = .01)。
- 腔内修复中支架置入率2.8%,高于开放修复的0.5%(P < .01)。
核心结论
- 开放修复术后再手术负担在纳入所有腹部并发症后可能高于当前认识。
- 腔内修复是再手术的负性预测因素(P < .001)。
- 随着腔内技术进展,应与开放修复频繁再评估并发症比较。
研究设计与样本
- 回顾性 review 退伍军人事务部外科质量改进项目数据。
- 纳入2007年10月1日至2013年10月1日所有腹主动脉瘤修复患者,共6677例。
主要发现
- 6677例中476例(7.1%)需再手术。
- 开放修复总体再手术率10.0%,高于腔内修复的6.3%(P < .01),多为腹腔内和伤口并发症。
- 开放修复肠缺血需手术率0.7% vs 腔内0.3%(P = .01),下肢缺血率0.5% vs 0.06%(P < .01)。
- 腔内修复中支架置入率2.8% vs 开放修复0.5%(P < .01)。
- Logistic回归控制合并症后,腔内修复为再手术负性预测因素(P < .001)。
关键数值与推荐
- 再手术定义包括腹主动脉或髂动脉后续开放或腔内手术、时间相关肠梗阻手术、≤6个月腹部或腹股沟伤口并发症处理、≤10天肠或下肢缺血处理。
临床怎么用
- 评估腹主动脉瘤修复方式时,应综合考虑开放修复术后再手术负担。
- 未来前瞻性试验应纳入>30天的所有潜在再手术及费用分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study compared reoperation rates associated with open abdominal aortic aneurysm (AAA) repair (OR) outcomes vs endovascular AAA repair (EVAR). METHODS: A retrospective review of the Veterans Affairs Surgical Quality Improvement Project data was performed with inclusion criteria defined as all patients who underwent AAA repair from October 1, 2007, to October 1, 2013. The primary outcome was the incidence of reoperations. Reoperations included subsequent OR or EVAR procedures performed on the abdominal aorta or iliac arteries, surgical treatment of temporally related bowel obstruction, as well as treatment of abdominal or groin wound complications ≤6 months and treatment of bowel or lower limb ischemia ≤10 days. RESULTS: Of 6677 patients who underwent AAA repair, 476 (7.1%) required reoperations. OR was associated with a higher rate of reoperations overall (10.0% vs 6.3%; P < .01), with most being intra-abdominal and wound complications. OR also had higher rates of bowel ischemia requiring operation (0.7% vs 0.3%; P = .01) and lower extremity ischemia (0.5% and 0.06%; P < .01). Significantly more endovascular stents were placed during EVAR (2.8% vs 0.5%; P < .01). Logistic regression showed EVAR is a negative predictor for reoperation after controlling for comorbidities (P < .001). CONCLUSIONS: The long-term burden of reoperations after OR may actually be more significant than current understanding when including all possible abdominal complications in an extended analysis. Future prospective trials should include all potential reoperations extended >30 days with associated cost analysis. As surgical innovation in EVAR technology advances, complication comparisons with OR should undergo frequent re-evaluation given that endovascular indications and outcomes continue to expand and improve.
引用
- Hynes CF, Endicott KM, Iranmanesh S, et al. Reoperation rates after open and endovascular abdominal aortic aneurysm repairs. J Vasc Surg. 2017. PMID: 28073669. doi:10.1016/j.jvs.2016.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。